Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome

被引:32
作者
de Bortoli, Nicola [1 ]
Martinucci, Irene [1 ]
Bellini, Massimo [1 ]
Savarino, Edoardo [2 ]
Savarino, Vincenzo [3 ]
Blandizzi, Corrado [4 ]
Marchi, Santino [1 ]
机构
[1] Univ Pisa, Div Gastroenterol, I-56124 Pisa, Italy
[2] Univ Padua, Div Gastroenterol, I-35100 Padua, Italy
[3] Univ Genoa, Div Gastroenterol, I-16100 Genoa, Italy
[4] Univ Pisa, Div Pharmacol & Chemotherapy, I-56124 Pisa, Italy
关键词
Functional gastrointestinal disorders; Gastroesophageal reflux disease/Gastro-oesophageal reflux disease; Irritable bowel syndrome; Acidity (esophageal); Hypersensitivity; QUALITY-OF-LIFE; LOWER GASTROINTESTINAL SYMPTOMS; PROTON-PUMP INHIBITORS; NONEROSIVE REFLUX; GENERAL-POPULATION; ESOPHAGEAL HYPERSENSITIVITY; ACID REFLUX; PSYCHOLOGICAL DISTRESS; DOUBLE-BLIND; RISK-FACTORS;
D O I
10.3748/wjg.v19.i35.5787
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Several studies indicate a significant degree of overlap between irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). Likewise, both functional heartburn (FH) and IBS are functional digestive disorders that may occur in the same patients. However, data establishing a solid link between FH and IBS are lacking, mainly because the clinical definition of FH has undergone substantial changes over the years. The available literature on the overlap between GERD or FH and IBS highlights considerable heterogeneity in terms of the criteria and diagnostic procedures used to assess heartburn and IBS. In particular, several epidemiological studies included patients with concomitant IBS and GERD without any attempt to distinguish FH (as defined by the Rome. criteria) from GERD via pathophysiological investigations. Independent of these critical issues, there is preliminary evidence supporting a significant degree of FH-IBS overlap. This underscores the need for studies based on updated diagnostic criteria and accurate pathophysiological classifications, particularly to distinguish FH from GERD. This distinction would represent an essential starting point to achieving a better understanding of pathophysiology in the subclasses of patients with GERD and FH and properly assessing the different degrees of overlap between IBS and the subcategories of heartburn. The present review article intends to appraise and critically discuss current evidence supporting a possible concomitance of GERD or FH with IBS in the same patients and to highlight the pathophysiological relationships between these disorders. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:5787 / 5797
页数:11
相关论文
共 88 条
  • [1] Impact of upper digestive symptoms in patients with irritable bowel syndrome
    Balboa, Agustin
    Mearin, Fermin
    Badia, Xavier
    Benavent, Jaume
    Maria Caballero, Antonio
    Dominguez-Munoz, Jos Enrique
    Garrigues, Vicente
    Maria Pique, Jose
    Roset, Montse
    Cucala, Mercedes
    Figueras, Montse
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (12) : 1271 - 1277
  • [2] Evaluation of GERD symptoms during therapy -: Part I.: Development of the new GERD questionnaire ReQuest™
    Bardhan, KD
    Stanghellini, V
    Armstrong, D
    Berghöfer, P
    Gatz, G
    Mönnikes, H
    [J]. DIGESTION, 2004, 69 (04) : 229 - 237
  • [3] Evaluation of latent links between irritable bowel syndrome and sleep quality
    Bellini, Massimo
    Gemignani, Angelo
    Gambaccini, Dario
    Toti, Simona
    Menicucci, Danilo
    Stasi, Cristina
    Costa, Francesco
    Mumolo, Maria Gloria
    Ricchiuti, Angelo
    Bedini, Remo
    de Bortoli, Nicola
    Marchi, Santino
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (46) : 5089 - 5096
  • [4] Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility
    Bhalla, V
    Liu, JM
    Puckett, JL
    Mittal, RK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 287 (01): : G65 - G71
  • [5] Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study
    Broekaert, D
    Fischler, B
    Sifrim, D
    Janssens, J
    Tack, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 365 - 370
  • [6] Bueno L, 2004, GASTROENTEROLOGY, V126, pA376
  • [7] Endoscopic and symptoms analysis in Mexican patients with irritable Bowel syndrome, dyspepsia, and gastroesophageal reflux disease
    Camacho, Santiago
    Bernal, Fernando
    Abdo, Miguel
    Awad, Richard A.
    [J]. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2010, 82 (04): : 953 - 962
  • [8] Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population
    Cheung, T. K.
    Lam, K. F.
    Hu, W. H. C.
    Lam, C. L. K.
    Wong, W. M.
    Hui, W. M.
    Lai, K. C.
    Lam, S. K.
    Wong, B. C. Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (09) : 1099 - 1104
  • [9] Chey WD, 2004, GASTROENTEROLOGY, V126, pA641
  • [10] LOW-DOSE TRAZODONE FOR SYMPTOMATIC PATIENTS WITH ESOPHAGEAL CONTRACTION ABNORMALITIES - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    CLOUSE, RE
    LUSTMAN, PJ
    ECKERT, TC
    FERNEY, DM
    GRIFFITH, LS
    [J]. GASTROENTEROLOGY, 1987, 92 (04) : 1027 - 1036